Latest news
Braveheart charges past expectations with $382.5M IPO to fund cardio drug from Hengrui - Fierce BiotechFierce Biotech · Thu, 06 Aug 2026 12:27:37 GMTCardiac drug developer Braveheart banks more than $382M in IPO - Yahoo FinanceYahoo Finance · Wed, 05 Aug 2026 20:01:00 GMTAttovia’s Upsized IPO Brings In $289M to Fund New Kind of Biologic for Immune Disorders - MedCity NewsMedCity News · Wed, 05 Aug 2026 18:46:44 GMTAttovia completes upsized IPO for USD 289m take-home - AllSciAllSci · Wed, 05 Aug 2026 16:14:09 GMTApnimed’s IPO dream comes true with upsized $192M IPO to fund sleep apnea pill launch - Fierce BiotechFierce Biotech · Fri, 31 Jul 2026 07:00:00 GMTApnimed raises $192M in upsized IPO to bring sleep apnea pill to market - DealroomDealroom · Fri, 31 Jul 2026 03:40:37 GMT